,id,sample.size,sex,category,subcategory,unit,group_name,build,author,year,population,trait,pmid,ontology,filename,nsnp,delimiter,header,mr,snp_col,chr_col,pos_col,ea_col,oa_col,eaf_col,beta_col,se_col,pval_col
1,med-d-Acetate_agetert1,37113,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Acetate,NA,NA,acetate_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
2,med-d-Acetate_agetert2,38774,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Acetate,NA,NA,acetate_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
3,med-d-Acetate_agetert3,39159,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Acetate,NA,NA,acetate_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
4,med-d-Acetoacetate_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Acetoacetate,NA,NA,acetoacetate_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
5,med-d-Acetoacetate_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Acetoacetate,NA,NA,acetoacetate_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
6,med-d-Acetoacetate_agetert3,39164,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Acetoacetate,NA,NA,acetoacetate_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
7,med-d-Acetone_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Acetone,NA,NA,acetone_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
8,med-d-Acetone_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Acetone,NA,NA,acetone_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
9,med-d-Acetone_agetert3,39164,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Acetone,NA,NA,acetone_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
10,med-d-Ala_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Alanine,NA,NA,ala_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
11,med-d-Ala_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Alanine,NA,NA,ala_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
12,med-d-Ala_agetert3,39163,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Alanine,NA,NA,ala_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
13,med-d-Albumin_agetert1,37120,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Albumin,NA,NA,albumin_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
14,med-d-Albumin_agetert2,38776,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Albumin,NA,NA,albumin_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
15,med-d-Albumin_agetert3,39164,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Albumin,NA,NA,albumin_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
16,med-d-ApoA1_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Apolipoprotein A1,NA,NA,apoa1_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
17,med-d-ApoA1_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Apolipoprotein A1,NA,NA,apoa1_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
18,med-d-ApoA1_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Apolipoprotein A1,NA,NA,apoa1_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
19,med-d-ApoB_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Apolipoprotein B,NA,NA,apob_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
20,med-d-ApoB_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Apolipoprotein B,NA,NA,apob_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
21,med-d-ApoB_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Apolipoprotein B,NA,NA,apob_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
22,med-d-ApoB_by_ApoA1_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of apolipoprotein B to apolipoprotein A1,NA,NA,apob_by_apoa1_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
23,med-d-ApoB_by_ApoA1_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of apolipoprotein B to apolipoprotein A1,NA,NA,apob_by_apoa1_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
24,med-d-ApoB_by_ApoA1_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of apolipoprotein B to apolipoprotein A1,NA,NA,apob_by_apoa1_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
25,med-d-bOHbutyrate_agetert1,36669,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,3-Hydroxybutyrate,NA,NA,bohbutyrate_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
26,med-d-bOHbutyrate_agetert2,38278,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,3-Hydroxybutyrate,NA,NA,bohbutyrate_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
27,med-d-bOHbutyrate_agetert3,38648,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,3-Hydroxybutyrate,NA,NA,bohbutyrate_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
28,med-d-Cholines_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total cholines,NA,NA,cholines_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
29,med-d-Cholines_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total cholines,NA,NA,cholines_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
30,med-d-Cholines_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total cholines,NA,NA,cholines_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
31,med-d-Citrate_agetert1,37119,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Citrate,NA,NA,citrate_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
32,med-d-Citrate_agetert2,38783,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Citrate,NA,NA,citrate_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
33,med-d-Citrate_agetert3,39162,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Citrate,NA,NA,citrate_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
34,med-d-Clinical_LDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Clinical LDL cholesterol,NA,NA,clinical_ldl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
35,med-d-Clinical_LDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Clinical LDL cholesterol,NA,NA,clinical_ldl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
36,med-d-Clinical_LDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Clinical LDL cholesterol,NA,NA,clinical_ldl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
37,med-d-Creatinine_agetert1,35449,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Creatinine,NA,NA,creatinine_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
38,med-d-Creatinine_agetert2,37035,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Creatinine,NA,NA,creatinine_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
39,med-d-Creatinine_agetert3,37574,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Creatinine,NA,NA,creatinine_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
40,med-d-DHA_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Docosahexaenoic acid,NA,NA,dha_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
41,med-d-DHA_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Docosahexaenoic acid,NA,NA,dha_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
42,med-d-DHA_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Docosahexaenoic acid,NA,NA,dha_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
43,med-d-DHA_pct_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of docosahexaenoic acid to total fatty acids,NA,NA,dha_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
44,med-d-DHA_pct_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of docosahexaenoic acid to total fatty acids,NA,NA,dha_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
45,med-d-DHA_pct_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of docosahexaenoic acid to total fatty acids,NA,NA,dha_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
46,med-d-Gln_agetert1,37016,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Glutamine,NA,NA,gln_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
47,med-d-Gln_agetert2,38682,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Glutamine,NA,NA,gln_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
48,med-d-Gln_agetert3,39052,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Glutamine,NA,NA,gln_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
49,med-d-Glucose_agetert1,37067,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Glucose,NA,NA,glucose_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
50,med-d-Glucose_agetert2,38703,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Glucose,NA,NA,glucose_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
51,med-d-Glucose_agetert3,39097,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Glucose,NA,NA,glucose_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
52,med-d-Gly_agetert1,37097,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Glycine,NA,NA,gly_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
53,med-d-Gly_agetert2,38748,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Glycine,NA,NA,gly_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
54,med-d-Gly_agetert3,39127,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Glycine,NA,NA,gly_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
55,med-d-GlycA_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Glycoprotein acetyls,NA,NA,glyca_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
56,med-d-GlycA_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Glycoprotein acetyls,NA,NA,glyca_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
57,med-d-GlycA_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Glycoprotein acetyls,NA,NA,glyca_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
58,med-d-HDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,HDL cholesterol,NA,NA,hdl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
59,med-d-HDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,HDL cholesterol,NA,NA,hdl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
60,med-d-HDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,HDL cholesterol,NA,NA,hdl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
61,med-d-HDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in HDL,NA,NA,hdl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
62,med-d-HDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in HDL,NA,NA,hdl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
63,med-d-HDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in HDL,NA,NA,hdl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
64,med-d-HDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in HDL,NA,NA,hdl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
65,med-d-HDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in HDL,NA,NA,hdl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
66,med-d-HDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in HDL,NA,NA,hdl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
67,med-d-HDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in HDL,NA,NA,hdl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
68,med-d-HDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in HDL,NA,NA,hdl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
69,med-d-HDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in HDL,NA,NA,hdl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
70,med-d-HDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of HDL particles,NA,NA,hdl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
71,med-d-HDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of HDL particles,NA,NA,hdl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
72,med-d-HDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of HDL particles,NA,NA,hdl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
73,med-d-HDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in HDL,NA,NA,hdl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
74,med-d-HDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in HDL,NA,NA,hdl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
75,med-d-HDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in HDL,NA,NA,hdl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
76,med-d-HDL_size_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Average diameter for HDL particles,NA,NA,hdl_size_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
77,med-d-HDL_size_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Average diameter for HDL particles,NA,NA,hdl_size_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
78,med-d-HDL_size_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Average diameter for HDL particles,NA,NA,hdl_size_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
79,med-d-HDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in HDL,NA,NA,hdl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
80,med-d-HDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in HDL,NA,NA,hdl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
81,med-d-HDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in HDL,NA,NA,hdl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
82,med-d-His_agetert1,37069,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Histidine,NA,NA,his_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
83,med-d-His_agetert2,38722,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Histidine,NA,NA,his_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
84,med-d-His_agetert3,39104,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Histidine,NA,NA,his_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
85,med-d-IDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in IDL,NA,NA,idl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
86,med-d-IDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in IDL,NA,NA,idl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
87,med-d-IDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in IDL,NA,NA,idl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
88,med-d-IDL_C_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in IDL,NA,NA,idl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
89,med-d-IDL_C_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in IDL,NA,NA,idl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
90,med-d-IDL_C_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in IDL,NA,NA,idl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
91,med-d-IDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in IDL,NA,NA,idl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
92,med-d-IDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in IDL,NA,NA,idl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
93,med-d-IDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in IDL,NA,NA,idl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
94,med-d-IDL_CE_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in IDL,NA,NA,idl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
95,med-d-IDL_CE_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in IDL,NA,NA,idl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
96,med-d-IDL_CE_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in IDL,NA,NA,idl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
97,med-d-IDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in IDL,NA,NA,idl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
98,med-d-IDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in IDL,NA,NA,idl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
99,med-d-IDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in IDL,NA,NA,idl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
100,med-d-IDL_FC_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in IDL,NA,NA,idl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
101,med-d-IDL_FC_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in IDL,NA,NA,idl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
102,med-d-IDL_FC_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in IDL,NA,NA,idl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
103,med-d-IDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in IDL,NA,NA,idl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
104,med-d-IDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in IDL,NA,NA,idl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
105,med-d-IDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in IDL,NA,NA,idl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
106,med-d-IDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of IDL particles,NA,NA,idl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
107,med-d-IDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of IDL particles,NA,NA,idl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
108,med-d-IDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of IDL particles,NA,NA,idl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
109,med-d-IDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in IDL,NA,NA,idl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
110,med-d-IDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in IDL,NA,NA,idl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
111,med-d-IDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in IDL,NA,NA,idl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
112,med-d-IDL_PL_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in IDL,NA,NA,idl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
113,med-d-IDL_PL_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in IDL,NA,NA,idl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
114,med-d-IDL_PL_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in IDL,NA,NA,idl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
115,med-d-IDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in IDL,NA,NA,idl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
116,med-d-IDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in IDL,NA,NA,idl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
117,med-d-IDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in IDL,NA,NA,idl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
118,med-d-IDL_TG_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in IDL,NA,NA,idl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
119,med-d-IDL_TG_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in IDL,NA,NA,idl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
120,med-d-IDL_TG_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in IDL,NA,NA,idl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
121,med-d-Ile_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Isoleucine,NA,NA,ile_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
122,med-d-Ile_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Isoleucine,NA,NA,ile_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
123,med-d-Ile_agetert3,39164,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Isoleucine,NA,NA,ile_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
124,med-d-L_HDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in large HDL,NA,NA,l_hdl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
125,med-d-L_HDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in large HDL,NA,NA,l_hdl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
126,med-d-L_HDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in large HDL,NA,NA,l_hdl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
127,med-d-L_HDL_C_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in large HDL,NA,NA,l_hdl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
128,med-d-L_HDL_C_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in large HDL,NA,NA,l_hdl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
129,med-d-L_HDL_C_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in large HDL,NA,NA,l_hdl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
130,med-d-L_HDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in large HDL,NA,NA,l_hdl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
131,med-d-L_HDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in large HDL,NA,NA,l_hdl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
132,med-d-L_HDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in large HDL,NA,NA,l_hdl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
133,med-d-L_HDL_CE_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in large HDL,NA,NA,l_hdl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
134,med-d-L_HDL_CE_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in large HDL,NA,NA,l_hdl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
135,med-d-L_HDL_CE_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in large HDL,NA,NA,l_hdl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
136,med-d-L_HDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in large HDL,NA,NA,l_hdl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
137,med-d-L_HDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in large HDL,NA,NA,l_hdl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
138,med-d-L_HDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in large HDL,NA,NA,l_hdl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
139,med-d-L_HDL_FC_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in large HDL,NA,NA,l_hdl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
140,med-d-L_HDL_FC_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in large HDL,NA,NA,l_hdl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
141,med-d-L_HDL_FC_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in large HDL,NA,NA,l_hdl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
142,med-d-L_HDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in large HDL,NA,NA,l_hdl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
143,med-d-L_HDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in large HDL,NA,NA,l_hdl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
144,med-d-L_HDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in large HDL,NA,NA,l_hdl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
145,med-d-L_HDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of large HDL particles,NA,NA,l_hdl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
146,med-d-L_HDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of large HDL particles,NA,NA,l_hdl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
147,med-d-L_HDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of large HDL particles,NA,NA,l_hdl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
148,med-d-L_HDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in large HDL,NA,NA,l_hdl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
149,med-d-L_HDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in large HDL,NA,NA,l_hdl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
150,med-d-L_HDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in large HDL,NA,NA,l_hdl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
151,med-d-L_HDL_PL_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in large HDL,NA,NA,l_hdl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
152,med-d-L_HDL_PL_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in large HDL,NA,NA,l_hdl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
153,med-d-L_HDL_PL_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in large HDL,NA,NA,l_hdl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
154,med-d-L_HDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in large HDL,NA,NA,l_hdl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
155,med-d-L_HDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in large HDL,NA,NA,l_hdl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
156,med-d-L_HDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in large HDL,NA,NA,l_hdl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
157,med-d-L_HDL_TG_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in large HDL,NA,NA,l_hdl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
158,med-d-L_HDL_TG_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in large HDL,NA,NA,l_hdl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
159,med-d-L_HDL_TG_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in large HDL,NA,NA,l_hdl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
160,med-d-L_LDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in large LDL,NA,NA,l_ldl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
161,med-d-L_LDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in large LDL,NA,NA,l_ldl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
162,med-d-L_LDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in large LDL,NA,NA,l_ldl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
163,med-d-L_LDL_C_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in large LDL,NA,NA,l_ldl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
164,med-d-L_LDL_C_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in large LDL,NA,NA,l_ldl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
165,med-d-L_LDL_C_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in large LDL,NA,NA,l_ldl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
166,med-d-L_LDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in large LDL,NA,NA,l_ldl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
167,med-d-L_LDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in large LDL,NA,NA,l_ldl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
168,med-d-L_LDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in large LDL,NA,NA,l_ldl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
169,med-d-L_LDL_CE_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in large LDL,NA,NA,l_ldl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
170,med-d-L_LDL_CE_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in large LDL,NA,NA,l_ldl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
171,med-d-L_LDL_CE_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in large LDL,NA,NA,l_ldl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
172,med-d-L_LDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in large LDL,NA,NA,l_ldl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
173,med-d-L_LDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in large LDL,NA,NA,l_ldl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
174,med-d-L_LDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in large LDL,NA,NA,l_ldl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
175,med-d-L_LDL_FC_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in large LDL,NA,NA,l_ldl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
176,med-d-L_LDL_FC_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in large LDL,NA,NA,l_ldl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
177,med-d-L_LDL_FC_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in large LDL,NA,NA,l_ldl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
178,med-d-L_LDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in large LDL,NA,NA,l_ldl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
179,med-d-L_LDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in large LDL,NA,NA,l_ldl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
180,med-d-L_LDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in large LDL,NA,NA,l_ldl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
181,med-d-L_LDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of large LDL particles,NA,NA,l_ldl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
182,med-d-L_LDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of large LDL particles,NA,NA,l_ldl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
183,med-d-L_LDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of large LDL particles,NA,NA,l_ldl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
184,med-d-L_LDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in large LDL,NA,NA,l_ldl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
185,med-d-L_LDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in large LDL,NA,NA,l_ldl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
186,med-d-L_LDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in large LDL,NA,NA,l_ldl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
187,med-d-L_LDL_PL_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in large LDL,NA,NA,l_ldl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
188,med-d-L_LDL_PL_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in large LDL,NA,NA,l_ldl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
189,med-d-L_LDL_PL_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in large LDL,NA,NA,l_ldl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
190,med-d-L_LDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in large LDL,NA,NA,l_ldl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
191,med-d-L_LDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in large LDL,NA,NA,l_ldl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
192,med-d-L_LDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in large LDL,NA,NA,l_ldl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
193,med-d-L_LDL_TG_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in large LDL,NA,NA,l_ldl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
194,med-d-L_LDL_TG_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in large LDL,NA,NA,l_ldl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
195,med-d-L_LDL_TG_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in large LDL,NA,NA,l_ldl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
196,med-d-L_VLDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in large VLDL,NA,NA,l_vldl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
197,med-d-L_VLDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in large VLDL,NA,NA,l_vldl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
198,med-d-L_VLDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in large VLDL,NA,NA,l_vldl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
199,med-d-L_VLDL_C_pct_agetert1,37124,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in large VLDL,NA,NA,l_vldl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
200,med-d-L_VLDL_C_pct_agetert2,38778,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in large VLDL,NA,NA,l_vldl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
201,med-d-L_VLDL_C_pct_agetert3,39165,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in large VLDL,NA,NA,l_vldl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
202,med-d-L_VLDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in large VLDL,NA,NA,l_vldl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
203,med-d-L_VLDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in large VLDL,NA,NA,l_vldl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
204,med-d-L_VLDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in large VLDL,NA,NA,l_vldl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
205,med-d-L_VLDL_CE_pct_agetert1,37124,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in large VLDL,NA,NA,l_vldl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
206,med-d-L_VLDL_CE_pct_agetert2,38778,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in large VLDL,NA,NA,l_vldl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
207,med-d-L_VLDL_CE_pct_agetert3,39165,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in large VLDL,NA,NA,l_vldl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
208,med-d-L_VLDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in large VLDL,NA,NA,l_vldl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
209,med-d-L_VLDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in large VLDL,NA,NA,l_vldl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
210,med-d-L_VLDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in large VLDL,NA,NA,l_vldl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
211,med-d-L_VLDL_FC_pct_agetert1,37124,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in large VLDL,NA,NA,l_vldl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
212,med-d-L_VLDL_FC_pct_agetert2,38778,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in large VLDL,NA,NA,l_vldl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
213,med-d-L_VLDL_FC_pct_agetert3,39165,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in large VLDL,NA,NA,l_vldl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
214,med-d-L_VLDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in large VLDL,NA,NA,l_vldl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
215,med-d-L_VLDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in large VLDL,NA,NA,l_vldl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
216,med-d-L_VLDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in large VLDL,NA,NA,l_vldl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
217,med-d-L_VLDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of large VLDL particles,NA,NA,l_vldl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
218,med-d-L_VLDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of large VLDL particles,NA,NA,l_vldl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
219,med-d-L_VLDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of large VLDL particles,NA,NA,l_vldl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
220,med-d-L_VLDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in large VLDL,NA,NA,l_vldl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
221,med-d-L_VLDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in large VLDL,NA,NA,l_vldl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
222,med-d-L_VLDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in large VLDL,NA,NA,l_vldl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
223,med-d-L_VLDL_PL_pct_agetert1,37124,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in large VLDL,NA,NA,l_vldl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
224,med-d-L_VLDL_PL_pct_agetert2,38778,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in large VLDL,NA,NA,l_vldl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
225,med-d-L_VLDL_PL_pct_agetert3,39165,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in large VLDL,NA,NA,l_vldl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
226,med-d-L_VLDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in large VLDL,NA,NA,l_vldl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
227,med-d-L_VLDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in large VLDL,NA,NA,l_vldl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
228,med-d-L_VLDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in large VLDL,NA,NA,l_vldl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
229,med-d-L_VLDL_TG_pct_agetert1,37124,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in large VLDL,NA,NA,l_vldl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
230,med-d-L_VLDL_TG_pct_agetert2,38778,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in large VLDL,NA,NA,l_vldl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
231,med-d-L_VLDL_TG_pct_agetert3,39165,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in large VLDL,NA,NA,l_vldl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
232,med-d-LA_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Linoleic acid,NA,NA,la_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
233,med-d-LA_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Linoleic acid,NA,NA,la_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
234,med-d-LA_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Linoleic acid,NA,NA,la_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
235,med-d-LA_pct_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of linoleic acid to total fatty acids,NA,NA,la_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
236,med-d-LA_pct_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of linoleic acid to total fatty acids,NA,NA,la_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
237,med-d-LA_pct_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of linoleic acid to total fatty acids,NA,NA,la_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
238,med-d-Lactate_agetert1,37033,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Lactate,NA,NA,lactate_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
239,med-d-Lactate_agetert2,38698,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Lactate,NA,NA,lactate_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
240,med-d-Lactate_agetert3,39071,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Lactate,NA,NA,lactate_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
241,med-d-LDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,LDL cholesterol,NA,NA,ldl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
242,med-d-LDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,LDL cholesterol,NA,NA,ldl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
243,med-d-LDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,LDL cholesterol,NA,NA,ldl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
244,med-d-LDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in LDL,NA,NA,ldl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
245,med-d-LDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in LDL,NA,NA,ldl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
246,med-d-LDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in LDL,NA,NA,ldl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
247,med-d-LDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in LDL,NA,NA,ldl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
248,med-d-LDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in LDL,NA,NA,ldl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
249,med-d-LDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in LDL,NA,NA,ldl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
250,med-d-LDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in LDL,NA,NA,ldl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
251,med-d-LDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in LDL,NA,NA,ldl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
252,med-d-LDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in LDL,NA,NA,ldl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
253,med-d-LDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of LDL particles,NA,NA,ldl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
254,med-d-LDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of LDL particles,NA,NA,ldl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
255,med-d-LDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of LDL particles,NA,NA,ldl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
256,med-d-LDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in LDL,NA,NA,ldl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
257,med-d-LDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in LDL,NA,NA,ldl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
258,med-d-LDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in LDL,NA,NA,ldl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
259,med-d-LDL_size_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Average diameter for LDL particles,NA,NA,ldl_size_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
260,med-d-LDL_size_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Average diameter for LDL particles,NA,NA,ldl_size_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
261,med-d-LDL_size_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Average diameter for LDL particles,NA,NA,ldl_size_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
262,med-d-LDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in LDL,NA,NA,ldl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
263,med-d-LDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in LDL,NA,NA,ldl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
264,med-d-LDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in LDL,NA,NA,ldl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
265,med-d-Leu_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Leucine,NA,NA,leu_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
266,med-d-Leu_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Leucine,NA,NA,leu_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
267,med-d-Leu_agetert3,39163,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Leucine,NA,NA,leu_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
268,med-d-M_HDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in medium HDL,NA,NA,m_hdl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
269,med-d-M_HDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in medium HDL,NA,NA,m_hdl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
270,med-d-M_HDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in medium HDL,NA,NA,m_hdl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
271,med-d-M_HDL_C_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in medium HDL,NA,NA,m_hdl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
272,med-d-M_HDL_C_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in medium HDL,NA,NA,m_hdl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
273,med-d-M_HDL_C_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in medium HDL,NA,NA,m_hdl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
274,med-d-M_HDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in medium HDL,NA,NA,m_hdl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
275,med-d-M_HDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in medium HDL,NA,NA,m_hdl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
276,med-d-M_HDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in medium HDL,NA,NA,m_hdl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
277,med-d-M_HDL_CE_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in medium HDL,NA,NA,m_hdl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
278,med-d-M_HDL_CE_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in medium HDL,NA,NA,m_hdl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
279,med-d-M_HDL_CE_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in medium HDL,NA,NA,m_hdl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
280,med-d-M_HDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in medium HDL,NA,NA,m_hdl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
281,med-d-M_HDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in medium HDL,NA,NA,m_hdl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
282,med-d-M_HDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in medium HDL,NA,NA,m_hdl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
283,med-d-M_HDL_FC_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in medium HDL,NA,NA,m_hdl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
284,med-d-M_HDL_FC_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in medium HDL,NA,NA,m_hdl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
285,med-d-M_HDL_FC_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in medium HDL,NA,NA,m_hdl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
286,med-d-M_HDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in medium HDL,NA,NA,m_hdl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
287,med-d-M_HDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in medium HDL,NA,NA,m_hdl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
288,med-d-M_HDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in medium HDL,NA,NA,m_hdl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
289,med-d-M_HDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of medium HDL particles,NA,NA,m_hdl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
290,med-d-M_HDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of medium HDL particles,NA,NA,m_hdl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
291,med-d-M_HDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of medium HDL particles,NA,NA,m_hdl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
292,med-d-M_HDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in medium HDL,NA,NA,m_hdl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
293,med-d-M_HDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in medium HDL,NA,NA,m_hdl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
294,med-d-M_HDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in medium HDL,NA,NA,m_hdl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
295,med-d-M_HDL_PL_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in medium HDL,NA,NA,m_hdl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
296,med-d-M_HDL_PL_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in medium HDL,NA,NA,m_hdl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
297,med-d-M_HDL_PL_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in medium HDL,NA,NA,m_hdl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
298,med-d-M_HDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in medium HDL,NA,NA,m_hdl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
299,med-d-M_HDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in medium HDL,NA,NA,m_hdl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
300,med-d-M_HDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in medium HDL,NA,NA,m_hdl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
301,med-d-M_HDL_TG_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in medium HDL,NA,NA,m_hdl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
302,med-d-M_HDL_TG_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in medium HDL,NA,NA,m_hdl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
303,med-d-M_HDL_TG_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in medium HDL,NA,NA,m_hdl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
304,med-d-M_LDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in medium LDL,NA,NA,m_ldl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
305,med-d-M_LDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in medium LDL,NA,NA,m_ldl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
306,med-d-M_LDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in medium LDL,NA,NA,m_ldl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
307,med-d-M_LDL_C_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in medium LDL,NA,NA,m_ldl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
308,med-d-M_LDL_C_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in medium LDL,NA,NA,m_ldl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
309,med-d-M_LDL_C_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in medium LDL,NA,NA,m_ldl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
310,med-d-M_LDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in medium LDL,NA,NA,m_ldl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
311,med-d-M_LDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in medium LDL,NA,NA,m_ldl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
312,med-d-M_LDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in medium LDL,NA,NA,m_ldl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
313,med-d-M_LDL_CE_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in medium LDL,NA,NA,m_ldl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
314,med-d-M_LDL_CE_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in medium LDL,NA,NA,m_ldl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
315,med-d-M_LDL_CE_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in medium LDL,NA,NA,m_ldl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
316,med-d-M_LDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in medium LDL,NA,NA,m_ldl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
317,med-d-M_LDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in medium LDL,NA,NA,m_ldl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
318,med-d-M_LDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in medium LDL,NA,NA,m_ldl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
319,med-d-M_LDL_FC_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in medium LDL,NA,NA,m_ldl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
320,med-d-M_LDL_FC_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in medium LDL,NA,NA,m_ldl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
321,med-d-M_LDL_FC_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in medium LDL,NA,NA,m_ldl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
322,med-d-M_LDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in medium LDL,NA,NA,m_ldl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
323,med-d-M_LDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in medium LDL,NA,NA,m_ldl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
324,med-d-M_LDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in medium LDL,NA,NA,m_ldl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
325,med-d-M_LDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of medium LDL particles,NA,NA,m_ldl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
326,med-d-M_LDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of medium LDL particles,NA,NA,m_ldl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
327,med-d-M_LDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of medium LDL particles,NA,NA,m_ldl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
328,med-d-M_LDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in medium LDL,NA,NA,m_ldl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
329,med-d-M_LDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in medium LDL,NA,NA,m_ldl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
330,med-d-M_LDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in medium LDL,NA,NA,m_ldl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
331,med-d-M_LDL_PL_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in medium LDL,NA,NA,m_ldl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
332,med-d-M_LDL_PL_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in medium LDL,NA,NA,m_ldl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
333,med-d-M_LDL_PL_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in medium LDL,NA,NA,m_ldl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
334,med-d-M_LDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in medium LDL,NA,NA,m_ldl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
335,med-d-M_LDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in medium LDL,NA,NA,m_ldl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
336,med-d-M_LDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in medium LDL,NA,NA,m_ldl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
337,med-d-M_LDL_TG_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in medium LDL,NA,NA,m_ldl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
338,med-d-M_LDL_TG_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in medium LDL,NA,NA,m_ldl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
339,med-d-M_LDL_TG_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in medium LDL,NA,NA,m_ldl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
340,med-d-M_VLDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in medium VLDL,NA,NA,m_vldl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
341,med-d-M_VLDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in medium VLDL,NA,NA,m_vldl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
342,med-d-M_VLDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in medium VLDL,NA,NA,m_vldl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
343,med-d-M_VLDL_C_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in medium VLDL,NA,NA,m_vldl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
344,med-d-M_VLDL_C_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in medium VLDL,NA,NA,m_vldl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
345,med-d-M_VLDL_C_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in medium VLDL,NA,NA,m_vldl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
346,med-d-M_VLDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in medium VLDL,NA,NA,m_vldl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
347,med-d-M_VLDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in medium VLDL,NA,NA,m_vldl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
348,med-d-M_VLDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in medium VLDL,NA,NA,m_vldl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
349,med-d-M_VLDL_CE_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in medium VLDL,NA,NA,m_vldl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
350,med-d-M_VLDL_CE_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in medium VLDL,NA,NA,m_vldl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
351,med-d-M_VLDL_CE_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in medium VLDL,NA,NA,m_vldl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
352,med-d-M_VLDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in medium VLDL,NA,NA,m_vldl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
353,med-d-M_VLDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in medium VLDL,NA,NA,m_vldl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
354,med-d-M_VLDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in medium VLDL,NA,NA,m_vldl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
355,med-d-M_VLDL_FC_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in medium VLDL,NA,NA,m_vldl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
356,med-d-M_VLDL_FC_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in medium VLDL,NA,NA,m_vldl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
357,med-d-M_VLDL_FC_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in medium VLDL,NA,NA,m_vldl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
358,med-d-M_VLDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in medium VLDL,NA,NA,m_vldl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
359,med-d-M_VLDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in medium VLDL,NA,NA,m_vldl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
360,med-d-M_VLDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in medium VLDL,NA,NA,m_vldl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
361,med-d-M_VLDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of medium VLDL particles,NA,NA,m_vldl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
362,med-d-M_VLDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of medium VLDL particles,NA,NA,m_vldl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
363,med-d-M_VLDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of medium VLDL particles,NA,NA,m_vldl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
364,med-d-M_VLDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in medium VLDL,NA,NA,m_vldl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
365,med-d-M_VLDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in medium VLDL,NA,NA,m_vldl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
366,med-d-M_VLDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in medium VLDL,NA,NA,m_vldl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
367,med-d-M_VLDL_PL_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in medium VLDL,NA,NA,m_vldl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
368,med-d-M_VLDL_PL_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in medium VLDL,NA,NA,m_vldl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
369,med-d-M_VLDL_PL_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in medium VLDL,NA,NA,m_vldl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
370,med-d-M_VLDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in medium VLDL,NA,NA,m_vldl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
371,med-d-M_VLDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in medium VLDL,NA,NA,m_vldl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
372,med-d-M_VLDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in medium VLDL,NA,NA,m_vldl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
373,med-d-M_VLDL_TG_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in medium VLDL,NA,NA,m_vldl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
374,med-d-M_VLDL_TG_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in medium VLDL,NA,NA,m_vldl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
375,med-d-M_VLDL_TG_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in medium VLDL,NA,NA,m_vldl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
376,med-d-MUFA_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Monounsaturated fatty acids,NA,NA,mufa_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
377,med-d-MUFA_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Monounsaturated fatty acids,NA,NA,mufa_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
378,med-d-MUFA_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Monounsaturated fatty acids,NA,NA,mufa_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
379,med-d-MUFA_pct_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of monounsaturated fatty acids to total fatty acids,NA,NA,mufa_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
380,med-d-MUFA_pct_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of monounsaturated fatty acids to total fatty acids,NA,NA,mufa_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
381,med-d-MUFA_pct_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of monounsaturated fatty acids to total fatty acids,NA,NA,mufa_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
382,med-d-non_HDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total cholesterol minus HDL-C,NA,NA,non_hdl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
383,med-d-non_HDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total cholesterol minus HDL-C,NA,NA,non_hdl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
384,med-d-non_HDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total cholesterol minus HDL-C,NA,NA,non_hdl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
385,med-d-Omega_3_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Omega-3 fatty acids,NA,NA,omega_3_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
386,med-d-Omega_3_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Omega-3 fatty acids,NA,NA,omega_3_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
387,med-d-Omega_3_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Omega-3 fatty acids,NA,NA,omega_3_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
388,med-d-Omega_3_pct_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of omega-3 fatty acids to total fatty acids,NA,NA,omega_3_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
389,med-d-Omega_3_pct_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of omega-3 fatty acids to total fatty acids,NA,NA,omega_3_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
390,med-d-Omega_3_pct_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of omega-3 fatty acids to total fatty acids,NA,NA,omega_3_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
391,med-d-Omega_6_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Omega-6 fatty acids,NA,NA,omega_6_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
392,med-d-Omega_6_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Omega-6 fatty acids,NA,NA,omega_6_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
393,med-d-Omega_6_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Omega-6 fatty acids,NA,NA,omega_6_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
394,med-d-Omega_6_by_Omega_3_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of omega-6 fatty acids to omega-3 fatty acids,NA,NA,omega_6_by_omega_3_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
395,med-d-Omega_6_by_Omega_3_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of omega-6 fatty acids to omega-3 fatty acids,NA,NA,omega_6_by_omega_3_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
396,med-d-Omega_6_by_Omega_3_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of omega-6 fatty acids to omega-3 fatty acids,NA,NA,omega_6_by_omega_3_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
397,med-d-Omega_6_pct_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of omega-6 fatty acids to total fatty acids,NA,NA,omega_6_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
398,med-d-Omega_6_pct_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of omega-6 fatty acids to total fatty acids,NA,NA,omega_6_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
399,med-d-Omega_6_pct_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of omega-6 fatty acids to total fatty acids,NA,NA,omega_6_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
400,med-d-Phe_agetert1,37112,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phenylalanine,NA,NA,phe_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
401,med-d-Phe_agetert2,38765,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phenylalanine,NA,NA,phe_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
402,med-d-Phe_agetert3,39148,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phenylalanine,NA,NA,phe_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
403,med-d-Phosphatidylc_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phosphatidylcholines,NA,NA,phosphatidylc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
404,med-d-Phosphatidylc_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phosphatidylcholines,NA,NA,phosphatidylc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
405,med-d-Phosphatidylc_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phosphatidylcholines,NA,NA,phosphatidylc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
406,med-d-Phosphoglyc_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phosphoglycerides,NA,NA,phosphoglyc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
407,med-d-Phosphoglyc_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phosphoglycerides,NA,NA,phosphoglyc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
408,med-d-Phosphoglyc_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phosphoglycerides,NA,NA,phosphoglyc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
409,med-d-PUFA_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Polyunsaturated fatty acids,NA,NA,pufa_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
410,med-d-PUFA_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Polyunsaturated fatty acids,NA,NA,pufa_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
411,med-d-PUFA_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Polyunsaturated fatty acids,NA,NA,pufa_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
412,med-d-PUFA_by_MUFA_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of polyunsaturated fatty acids to monounsaturated fatty acids,NA,NA,pufa_by_mufa_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
413,med-d-PUFA_by_MUFA_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of polyunsaturated fatty acids to monounsaturated fatty acids,NA,NA,pufa_by_mufa_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
414,med-d-PUFA_by_MUFA_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of polyunsaturated fatty acids to monounsaturated fatty acids,NA,NA,pufa_by_mufa_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
415,med-d-PUFA_pct_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of polyunsaturated fatty acids to total fatty acids,NA,NA,pufa_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
416,med-d-PUFA_pct_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of polyunsaturated fatty acids to total fatty acids,NA,NA,pufa_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
417,med-d-PUFA_pct_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of polyunsaturated fatty acids to total fatty acids,NA,NA,pufa_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
418,med-d-Pyruvate_agetert1,37016,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Pyruvate,NA,NA,pyruvate_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
419,med-d-Pyruvate_agetert2,38682,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Pyruvate,NA,NA,pyruvate_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
420,med-d-Pyruvate_agetert3,39050,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Pyruvate,NA,NA,pyruvate_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
421,med-d-Remnant_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,"Remnant cholesterol (non-HDL, non-LDL -cholesterol)",NA,NA,remnant_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
422,med-d-Remnant_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,"Remnant cholesterol (non-HDL, non-LDL -cholesterol)",NA,NA,remnant_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
423,med-d-Remnant_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,"Remnant cholesterol (non-HDL, non-LDL -cholesterol)",NA,NA,remnant_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
424,med-d-S_HDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in small HDL,NA,NA,s_hdl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
425,med-d-S_HDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in small HDL,NA,NA,s_hdl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
426,med-d-S_HDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in small HDL,NA,NA,s_hdl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
427,med-d-S_HDL_C_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in small HDL,NA,NA,s_hdl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
428,med-d-S_HDL_C_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in small HDL,NA,NA,s_hdl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
429,med-d-S_HDL_C_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in small HDL,NA,NA,s_hdl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
430,med-d-S_HDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in small HDL,NA,NA,s_hdl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
431,med-d-S_HDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in small HDL,NA,NA,s_hdl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
432,med-d-S_HDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in small HDL,NA,NA,s_hdl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
433,med-d-S_HDL_CE_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in small HDL,NA,NA,s_hdl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
434,med-d-S_HDL_CE_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in small HDL,NA,NA,s_hdl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
435,med-d-S_HDL_CE_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in small HDL,NA,NA,s_hdl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
436,med-d-S_HDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in small HDL,NA,NA,s_hdl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
437,med-d-S_HDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in small HDL,NA,NA,s_hdl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
438,med-d-S_HDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in small HDL,NA,NA,s_hdl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
439,med-d-S_HDL_FC_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in small HDL,NA,NA,s_hdl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
440,med-d-S_HDL_FC_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in small HDL,NA,NA,s_hdl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
441,med-d-S_HDL_FC_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in small HDL,NA,NA,s_hdl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
442,med-d-S_HDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in small HDL,NA,NA,s_hdl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
443,med-d-S_HDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in small HDL,NA,NA,s_hdl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
444,med-d-S_HDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in small HDL,NA,NA,s_hdl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
445,med-d-S_HDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of small HDL particles,NA,NA,s_hdl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
446,med-d-S_HDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of small HDL particles,NA,NA,s_hdl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
447,med-d-S_HDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of small HDL particles,NA,NA,s_hdl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
448,med-d-S_HDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in small HDL,NA,NA,s_hdl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
449,med-d-S_HDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in small HDL,NA,NA,s_hdl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
450,med-d-S_HDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in small HDL,NA,NA,s_hdl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
451,med-d-S_HDL_PL_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in small HDL,NA,NA,s_hdl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
452,med-d-S_HDL_PL_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in small HDL,NA,NA,s_hdl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
453,med-d-S_HDL_PL_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in small HDL,NA,NA,s_hdl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
454,med-d-S_HDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in small HDL,NA,NA,s_hdl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
455,med-d-S_HDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in small HDL,NA,NA,s_hdl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
456,med-d-S_HDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in small HDL,NA,NA,s_hdl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
457,med-d-S_HDL_TG_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in small HDL,NA,NA,s_hdl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
458,med-d-S_HDL_TG_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in small HDL,NA,NA,s_hdl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
459,med-d-S_HDL_TG_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in small HDL,NA,NA,s_hdl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
460,med-d-S_LDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in small LDL,NA,NA,s_ldl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
461,med-d-S_LDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in small LDL,NA,NA,s_ldl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
462,med-d-S_LDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in small LDL,NA,NA,s_ldl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
463,med-d-S_LDL_C_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in small LDL,NA,NA,s_ldl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
464,med-d-S_LDL_C_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in small LDL,NA,NA,s_ldl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
465,med-d-S_LDL_C_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in small LDL,NA,NA,s_ldl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
466,med-d-S_LDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in small LDL,NA,NA,s_ldl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
467,med-d-S_LDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in small LDL,NA,NA,s_ldl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
468,med-d-S_LDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in small LDL,NA,NA,s_ldl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
469,med-d-S_LDL_CE_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in small LDL,NA,NA,s_ldl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
470,med-d-S_LDL_CE_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in small LDL,NA,NA,s_ldl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
471,med-d-S_LDL_CE_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in small LDL,NA,NA,s_ldl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
472,med-d-S_LDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in small LDL,NA,NA,s_ldl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
473,med-d-S_LDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in small LDL,NA,NA,s_ldl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
474,med-d-S_LDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in small LDL,NA,NA,s_ldl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
475,med-d-S_LDL_FC_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in small LDL,NA,NA,s_ldl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
476,med-d-S_LDL_FC_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in small LDL,NA,NA,s_ldl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
477,med-d-S_LDL_FC_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in small LDL,NA,NA,s_ldl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
478,med-d-S_LDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in small LDL,NA,NA,s_ldl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
479,med-d-S_LDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in small LDL,NA,NA,s_ldl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
480,med-d-S_LDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in small LDL,NA,NA,s_ldl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
481,med-d-S_LDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of small LDL particles,NA,NA,s_ldl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
482,med-d-S_LDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of small LDL particles,NA,NA,s_ldl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
483,med-d-S_LDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of small LDL particles,NA,NA,s_ldl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
484,med-d-S_LDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in small LDL,NA,NA,s_ldl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
485,med-d-S_LDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in small LDL,NA,NA,s_ldl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
486,med-d-S_LDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in small LDL,NA,NA,s_ldl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
487,med-d-S_LDL_PL_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in small LDL,NA,NA,s_ldl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
488,med-d-S_LDL_PL_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in small LDL,NA,NA,s_ldl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
489,med-d-S_LDL_PL_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in small LDL,NA,NA,s_ldl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
490,med-d-S_LDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in small LDL,NA,NA,s_ldl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
491,med-d-S_LDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in small LDL,NA,NA,s_ldl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
492,med-d-S_LDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in small LDL,NA,NA,s_ldl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
493,med-d-S_LDL_TG_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in small LDL,NA,NA,s_ldl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
494,med-d-S_LDL_TG_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in small LDL,NA,NA,s_ldl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
495,med-d-S_LDL_TG_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in small LDL,NA,NA,s_ldl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
496,med-d-S_VLDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in small VLDL,NA,NA,s_vldl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
497,med-d-S_VLDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in small VLDL,NA,NA,s_vldl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
498,med-d-S_VLDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in small VLDL,NA,NA,s_vldl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
499,med-d-S_VLDL_C_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in small VLDL,NA,NA,s_vldl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
500,med-d-S_VLDL_C_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in small VLDL,NA,NA,s_vldl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
501,med-d-S_VLDL_C_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in small VLDL,NA,NA,s_vldl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
502,med-d-S_VLDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in small VLDL,NA,NA,s_vldl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
503,med-d-S_VLDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in small VLDL,NA,NA,s_vldl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
504,med-d-S_VLDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in small VLDL,NA,NA,s_vldl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
505,med-d-S_VLDL_CE_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in small VLDL,NA,NA,s_vldl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
506,med-d-S_VLDL_CE_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in small VLDL,NA,NA,s_vldl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
507,med-d-S_VLDL_CE_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in small VLDL,NA,NA,s_vldl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
508,med-d-S_VLDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in small VLDL,NA,NA,s_vldl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
509,med-d-S_VLDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in small VLDL,NA,NA,s_vldl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
510,med-d-S_VLDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in small VLDL,NA,NA,s_vldl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
511,med-d-S_VLDL_FC_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in small VLDL,NA,NA,s_vldl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
512,med-d-S_VLDL_FC_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in small VLDL,NA,NA,s_vldl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
513,med-d-S_VLDL_FC_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in small VLDL,NA,NA,s_vldl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
514,med-d-S_VLDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in small VLDL,NA,NA,s_vldl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
515,med-d-S_VLDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in small VLDL,NA,NA,s_vldl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
516,med-d-S_VLDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in small VLDL,NA,NA,s_vldl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
517,med-d-S_VLDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of small VLDL particles,NA,NA,s_vldl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
518,med-d-S_VLDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of small VLDL particles,NA,NA,s_vldl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
519,med-d-S_VLDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of small VLDL particles,NA,NA,s_vldl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
520,med-d-S_VLDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in small VLDL,NA,NA,s_vldl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
521,med-d-S_VLDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in small VLDL,NA,NA,s_vldl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
522,med-d-S_VLDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in small VLDL,NA,NA,s_vldl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
523,med-d-S_VLDL_PL_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in small VLDL,NA,NA,s_vldl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
524,med-d-S_VLDL_PL_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in small VLDL,NA,NA,s_vldl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
525,med-d-S_VLDL_PL_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in small VLDL,NA,NA,s_vldl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
526,med-d-S_VLDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in small VLDL,NA,NA,s_vldl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
527,med-d-S_VLDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in small VLDL,NA,NA,s_vldl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
528,med-d-S_VLDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in small VLDL,NA,NA,s_vldl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
529,med-d-S_VLDL_TG_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in small VLDL,NA,NA,s_vldl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
530,med-d-S_VLDL_TG_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in small VLDL,NA,NA,s_vldl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
531,med-d-S_VLDL_TG_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in small VLDL,NA,NA,s_vldl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
532,med-d-SFA_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Saturated fatty acids,NA,NA,sfa_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
533,med-d-SFA_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Saturated fatty acids,NA,NA,sfa_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
534,med-d-SFA_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Saturated fatty acids,NA,NA,sfa_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
535,med-d-SFA_pct_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of saturated fatty acids to total fatty acids,NA,NA,sfa_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
536,med-d-SFA_pct_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of saturated fatty acids to total fatty acids,NA,NA,sfa_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
537,med-d-SFA_pct_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of saturated fatty acids to total fatty acids,NA,NA,sfa_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
538,med-d-Sphingomyelins_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Sphingomyelins,NA,NA,sphingomyelins_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
539,med-d-Sphingomyelins_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Sphingomyelins,NA,NA,sphingomyelins_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
540,med-d-Sphingomyelins_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Sphingomyelins,NA,NA,sphingomyelins_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
541,med-d-TG_by_PG_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of triglycerides to phosphoglycerides,NA,NA,tg_by_pg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
542,med-d-TG_by_PG_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of triglycerides to phosphoglycerides,NA,NA,tg_by_pg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
543,med-d-TG_by_PG_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Ratio of triglycerides to phosphoglycerides,NA,NA,tg_by_pg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
544,med-d-Total_BCAA_agetert1,37114,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total concentration of branched-chain amino acids (leucine + isoleucine + valine),NA,NA,total_bcaa_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
545,med-d-Total_BCAA_agetert2,38773,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total concentration of branched-chain amino acids (leucine + isoleucine + valine),NA,NA,total_bcaa_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
546,med-d-Total_BCAA_agetert3,39160,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total concentration of branched-chain amino acids (leucine + isoleucine + valine),NA,NA,total_bcaa_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
547,med-d-Total_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total cholesterol,NA,NA,total_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
548,med-d-Total_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total cholesterol,NA,NA,total_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
549,med-d-Total_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total cholesterol,NA,NA,total_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
550,med-d-Total_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total esterified cholesterol,NA,NA,total_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
551,med-d-Total_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total esterified cholesterol,NA,NA,total_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
552,med-d-Total_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total esterified cholesterol,NA,NA,total_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
553,med-d-Total_FA_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total fatty acids,NA,NA,total_fa_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
554,med-d-Total_FA_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total fatty acids,NA,NA,total_fa_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
555,med-d-Total_FA_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total fatty acids,NA,NA,total_fa_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
556,med-d-Total_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total free cholesterol,NA,NA,total_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
557,med-d-Total_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total free cholesterol,NA,NA,total_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
558,med-d-Total_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total free cholesterol,NA,NA,total_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
559,med-d-Total_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in lipoprotein particles,NA,NA,total_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
560,med-d-Total_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in lipoprotein particles,NA,NA,total_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
561,med-d-Total_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in lipoprotein particles,NA,NA,total_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
562,med-d-Total_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total concentration of lipoprotein particles,NA,NA,total_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
563,med-d-Total_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total concentration of lipoprotein particles,NA,NA,total_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
564,med-d-Total_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total concentration of lipoprotein particles,NA,NA,total_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
565,med-d-Total_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total phospholipids in lipoprotein particles,NA,NA,total_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
566,med-d-Total_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total phospholipids in lipoprotein particles,NA,NA,total_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
567,med-d-Total_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total phospholipids in lipoprotein particles,NA,NA,total_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
568,med-d-Total_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total triglycerides,NA,NA,total_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
569,med-d-Total_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total triglycerides,NA,NA,total_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
570,med-d-Total_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total triglycerides,NA,NA,total_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
571,med-d-Tyr_agetert1,37072,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Tyrosine,NA,NA,tyr_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
572,med-d-Tyr_agetert2,38728,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Tyrosine,NA,NA,tyr_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
573,med-d-Tyr_agetert3,39111,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Tyrosine,NA,NA,tyr_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
574,med-d-Unsaturation_agetert1,37095,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Degree of unsaturation,NA,NA,unsaturation_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
575,med-d-Unsaturation_agetert2,38761,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Degree of unsaturation,NA,NA,unsaturation_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
576,med-d-Unsaturation_agetert3,39143,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Degree of unsaturation,NA,NA,unsaturation_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
577,med-d-Val_agetert1,37114,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Valine,NA,NA,val_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
578,med-d-Val_agetert2,38773,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Valine,NA,NA,val_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
579,med-d-Val_agetert3,39161,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Valine,NA,NA,val_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
580,med-d-VLDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,VLDL cholesterol,NA,NA,vldl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
581,med-d-VLDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,VLDL cholesterol,NA,NA,vldl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
582,med-d-VLDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,VLDL cholesterol,NA,NA,vldl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
583,med-d-VLDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in VLDL,NA,NA,vldl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
584,med-d-VLDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in VLDL,NA,NA,vldl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
585,med-d-VLDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in VLDL,NA,NA,vldl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
586,med-d-VLDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in VLDL,NA,NA,vldl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
587,med-d-VLDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in VLDL,NA,NA,vldl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
588,med-d-VLDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in VLDL,NA,NA,vldl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
589,med-d-VLDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in VLDL,NA,NA,vldl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
590,med-d-VLDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in VLDL,NA,NA,vldl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
591,med-d-VLDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in VLDL,NA,NA,vldl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
592,med-d-VLDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of VLDL particles,NA,NA,vldl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
593,med-d-VLDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of VLDL particles,NA,NA,vldl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
594,med-d-VLDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of VLDL particles,NA,NA,vldl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
595,med-d-VLDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in VLDL,NA,NA,vldl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
596,med-d-VLDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in VLDL,NA,NA,vldl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
597,med-d-VLDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in VLDL,NA,NA,vldl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
598,med-d-VLDL_size_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Average diameter for VLDL particles,NA,NA,vldl_size_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
599,med-d-VLDL_size_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Average diameter for VLDL particles,NA,NA,vldl_size_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
600,med-d-VLDL_size_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Average diameter for VLDL particles,NA,NA,vldl_size_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
601,med-d-VLDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in VLDL,NA,NA,vldl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
602,med-d-VLDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in VLDL,NA,NA,vldl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
603,med-d-VLDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in VLDL,NA,NA,vldl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
604,med-d-XL_HDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in very large HDL,NA,NA,xl_hdl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
605,med-d-XL_HDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in very large HDL,NA,NA,xl_hdl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
606,med-d-XL_HDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in very large HDL,NA,NA,xl_hdl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
607,med-d-XL_HDL_C_pct_agetert1,37124,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in very large HDL,NA,NA,xl_hdl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
608,med-d-XL_HDL_C_pct_agetert2,38769,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in very large HDL,NA,NA,xl_hdl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
609,med-d-XL_HDL_C_pct_agetert3,39160,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in very large HDL,NA,NA,xl_hdl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
610,med-d-XL_HDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in very large HDL,NA,NA,xl_hdl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
611,med-d-XL_HDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in very large HDL,NA,NA,xl_hdl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
612,med-d-XL_HDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in very large HDL,NA,NA,xl_hdl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
613,med-d-XL_HDL_CE_pct_agetert1,37124,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in very large HDL,NA,NA,xl_hdl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
614,med-d-XL_HDL_CE_pct_agetert2,38769,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in very large HDL,NA,NA,xl_hdl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
615,med-d-XL_HDL_CE_pct_agetert3,39160,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in very large HDL,NA,NA,xl_hdl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
616,med-d-XL_HDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in very large HDL,NA,NA,xl_hdl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
617,med-d-XL_HDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in very large HDL,NA,NA,xl_hdl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
618,med-d-XL_HDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in very large HDL,NA,NA,xl_hdl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
619,med-d-XL_HDL_FC_pct_agetert1,37124,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in very large HDL,NA,NA,xl_hdl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
620,med-d-XL_HDL_FC_pct_agetert2,38769,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in very large HDL,NA,NA,xl_hdl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
621,med-d-XL_HDL_FC_pct_agetert3,39160,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in very large HDL,NA,NA,xl_hdl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
622,med-d-XL_HDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in very large HDL,NA,NA,xl_hdl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
623,med-d-XL_HDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in very large HDL,NA,NA,xl_hdl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
624,med-d-XL_HDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in very large HDL,NA,NA,xl_hdl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
625,med-d-XL_HDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of very large HDL particles,NA,NA,xl_hdl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
626,med-d-XL_HDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of very large HDL particles,NA,NA,xl_hdl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
627,med-d-XL_HDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of very large HDL particles,NA,NA,xl_hdl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
628,med-d-XL_HDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in very large HDL,NA,NA,xl_hdl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
629,med-d-XL_HDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in very large HDL,NA,NA,xl_hdl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
630,med-d-XL_HDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in very large HDL,NA,NA,xl_hdl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
631,med-d-XL_HDL_PL_pct_agetert1,37124,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in very large HDL,NA,NA,xl_hdl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
632,med-d-XL_HDL_PL_pct_agetert2,38769,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in very large HDL,NA,NA,xl_hdl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
633,med-d-XL_HDL_PL_pct_agetert3,39160,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in very large HDL,NA,NA,xl_hdl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
634,med-d-XL_HDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in very large HDL,NA,NA,xl_hdl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
635,med-d-XL_HDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in very large HDL,NA,NA,xl_hdl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
636,med-d-XL_HDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in very large HDL,NA,NA,xl_hdl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
637,med-d-XL_HDL_TG_pct_agetert1,37124,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in very large HDL,NA,NA,xl_hdl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
638,med-d-XL_HDL_TG_pct_agetert2,38769,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in very large HDL,NA,NA,xl_hdl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
639,med-d-XL_HDL_TG_pct_agetert3,39160,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in very large HDL,NA,NA,xl_hdl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
640,med-d-XL_VLDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in very large VLDL,NA,NA,xl_vldl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
641,med-d-XL_VLDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in very large VLDL,NA,NA,xl_vldl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
642,med-d-XL_VLDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in very large VLDL,NA,NA,xl_vldl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
643,med-d-XL_VLDL_C_pct_agetert1,36794,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in very large VLDL,NA,NA,xl_vldl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
644,med-d-XL_VLDL_C_pct_agetert2,38492,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in very large VLDL,NA,NA,xl_vldl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
645,med-d-XL_VLDL_C_pct_agetert3,38869,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in very large VLDL,NA,NA,xl_vldl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
646,med-d-XL_VLDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in very large VLDL,NA,NA,xl_vldl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
647,med-d-XL_VLDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in very large VLDL,NA,NA,xl_vldl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
648,med-d-XL_VLDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in very large VLDL,NA,NA,xl_vldl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
649,med-d-XL_VLDL_CE_pct_agetert1,36794,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in very large VLDL,NA,NA,xl_vldl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
650,med-d-XL_VLDL_CE_pct_agetert2,38492,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in very large VLDL,NA,NA,xl_vldl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
651,med-d-XL_VLDL_CE_pct_agetert3,38869,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in very large VLDL,NA,NA,xl_vldl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
652,med-d-XL_VLDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in very large VLDL,NA,NA,xl_vldl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
653,med-d-XL_VLDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in very large VLDL,NA,NA,xl_vldl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
654,med-d-XL_VLDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in very large VLDL,NA,NA,xl_vldl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
655,med-d-XL_VLDL_FC_pct_agetert1,36794,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in very large VLDL,NA,NA,xl_vldl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
656,med-d-XL_VLDL_FC_pct_agetert2,38492,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in very large VLDL,NA,NA,xl_vldl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
657,med-d-XL_VLDL_FC_pct_agetert3,38869,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in very large VLDL,NA,NA,xl_vldl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
658,med-d-XL_VLDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in very large VLDL,NA,NA,xl_vldl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
659,med-d-XL_VLDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in very large VLDL,NA,NA,xl_vldl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
660,med-d-XL_VLDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in very large VLDL,NA,NA,xl_vldl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
661,med-d-XL_VLDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of very large VLDL particles,NA,NA,xl_vldl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
662,med-d-XL_VLDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of very large VLDL particles,NA,NA,xl_vldl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
663,med-d-XL_VLDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of very large VLDL particles,NA,NA,xl_vldl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
664,med-d-XL_VLDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in very large VLDL,NA,NA,xl_vldl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
665,med-d-XL_VLDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in very large VLDL,NA,NA,xl_vldl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
666,med-d-XL_VLDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in very large VLDL,NA,NA,xl_vldl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
667,med-d-XL_VLDL_PL_pct_agetert1,36794,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in very large VLDL,NA,NA,xl_vldl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
668,med-d-XL_VLDL_PL_pct_agetert2,38492,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in very large VLDL,NA,NA,xl_vldl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
669,med-d-XL_VLDL_PL_pct_agetert3,38869,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in very large VLDL,NA,NA,xl_vldl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
670,med-d-XL_VLDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in very large VLDL,NA,NA,xl_vldl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
671,med-d-XL_VLDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in very large VLDL,NA,NA,xl_vldl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
672,med-d-XL_VLDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in very large VLDL,NA,NA,xl_vldl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
673,med-d-XL_VLDL_TG_pct_agetert1,36794,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in very large VLDL,NA,NA,xl_vldl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
674,med-d-XL_VLDL_TG_pct_agetert2,38492,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in very large VLDL,NA,NA,xl_vldl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
675,med-d-XL_VLDL_TG_pct_agetert3,38869,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in very large VLDL,NA,NA,xl_vldl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
676,med-d-XS_VLDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in very small VLDL,NA,NA,xs_vldl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
677,med-d-XS_VLDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in very small VLDL,NA,NA,xs_vldl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
678,med-d-XS_VLDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in very small VLDL,NA,NA,xs_vldl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
679,med-d-XS_VLDL_C_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in very small VLDL,NA,NA,xs_vldl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
680,med-d-XS_VLDL_C_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in very small VLDL,NA,NA,xs_vldl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
681,med-d-XS_VLDL_C_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in very small VLDL,NA,NA,xs_vldl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
682,med-d-XS_VLDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in very small VLDL,NA,NA,xs_vldl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
683,med-d-XS_VLDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in very small VLDL,NA,NA,xs_vldl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
684,med-d-XS_VLDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in very small VLDL,NA,NA,xs_vldl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
685,med-d-XS_VLDL_CE_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in very small VLDL,NA,NA,xs_vldl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
686,med-d-XS_VLDL_CE_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in very small VLDL,NA,NA,xs_vldl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
687,med-d-XS_VLDL_CE_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in very small VLDL,NA,NA,xs_vldl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
688,med-d-XS_VLDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in very small VLDL,NA,NA,xs_vldl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
689,med-d-XS_VLDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in very small VLDL,NA,NA,xs_vldl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
690,med-d-XS_VLDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in very small VLDL,NA,NA,xs_vldl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
691,med-d-XS_VLDL_FC_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in very small VLDL,NA,NA,xs_vldl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
692,med-d-XS_VLDL_FC_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in very small VLDL,NA,NA,xs_vldl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
693,med-d-XS_VLDL_FC_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in very small VLDL,NA,NA,xs_vldl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
694,med-d-XS_VLDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in very small VLDL,NA,NA,xs_vldl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
695,med-d-XS_VLDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in very small VLDL,NA,NA,xs_vldl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
696,med-d-XS_VLDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in very small VLDL,NA,NA,xs_vldl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
697,med-d-XS_VLDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of very small VLDL particles,NA,NA,xs_vldl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
698,med-d-XS_VLDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of very small VLDL particles,NA,NA,xs_vldl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
699,med-d-XS_VLDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of very small VLDL particles,NA,NA,xs_vldl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
700,med-d-XS_VLDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in very small VLDL,NA,NA,xs_vldl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
701,med-d-XS_VLDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in very small VLDL,NA,NA,xs_vldl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
702,med-d-XS_VLDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in very small VLDL,NA,NA,xs_vldl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
703,med-d-XS_VLDL_PL_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in very small VLDL,NA,NA,xs_vldl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
704,med-d-XS_VLDL_PL_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in very small VLDL,NA,NA,xs_vldl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
705,med-d-XS_VLDL_PL_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in very small VLDL,NA,NA,xs_vldl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
706,med-d-XS_VLDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in very small VLDL,NA,NA,xs_vldl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
707,med-d-XS_VLDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in very small VLDL,NA,NA,xs_vldl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
708,med-d-XS_VLDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in very small VLDL,NA,NA,xs_vldl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
709,med-d-XS_VLDL_TG_pct_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in very small VLDL,NA,NA,xs_vldl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
710,med-d-XS_VLDL_TG_pct_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in very small VLDL,NA,NA,xs_vldl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
711,med-d-XS_VLDL_TG_pct_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in very small VLDL,NA,NA,xs_vldl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
712,med-d-XXL_VLDL_C_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_c_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
713,med-d-XXL_VLDL_C_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_c_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
714,med-d-XXL_VLDL_C_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_c_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
715,med-d-XXL_VLDL_C_pct_agetert1,35865,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_c_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
716,med-d-XXL_VLDL_C_pct_agetert2,37666,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_c_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
717,med-d-XXL_VLDL_C_pct_agetert3,38100,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesterol to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_c_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
718,med-d-XXL_VLDL_CE_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_ce_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
719,med-d-XXL_VLDL_CE_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_ce_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
720,med-d-XXL_VLDL_CE_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_ce_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
721,med-d-XXL_VLDL_CE_pct_agetert1,35865,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_ce_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
722,med-d-XXL_VLDL_CE_pct_agetert2,37666,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_ce_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
723,med-d-XXL_VLDL_CE_pct_agetert3,38100,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Cholesteryl esters to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_ce_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
724,med-d-XXL_VLDL_FC_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_fc_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
725,med-d-XXL_VLDL_FC_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_fc_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
726,med-d-XXL_VLDL_FC_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_fc_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
727,med-d-XXL_VLDL_FC_pct_agetert1,35865,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_fc_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
728,med-d-XXL_VLDL_FC_pct_agetert2,37666,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_fc_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
729,med-d-XXL_VLDL_FC_pct_agetert3,38100,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_fc_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
730,med-d-XXL_VLDL_L_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_l_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
731,med-d-XXL_VLDL_L_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_l_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
732,med-d-XXL_VLDL_L_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Total lipids in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_l_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
733,med-d-XXL_VLDL_P_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of chylomicrons and extremely large VLDL particles,NA,NA,xxl_vldl_p_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
734,med-d-XXL_VLDL_P_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of chylomicrons and extremely large VLDL particles,NA,NA,xxl_vldl_p_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
735,med-d-XXL_VLDL_P_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Concentration of chylomicrons and extremely large VLDL particles,NA,NA,xxl_vldl_p_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
736,med-d-XXL_VLDL_PL_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_pl_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
737,med-d-XXL_VLDL_PL_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_pl_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
738,med-d-XXL_VLDL_PL_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_pl_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
739,med-d-XXL_VLDL_PL_pct_agetert1,35865,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_pl_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
740,med-d-XXL_VLDL_PL_pct_agetert2,37666,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_pl_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
741,med-d-XXL_VLDL_PL_pct_agetert3,38100,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Phospholipids to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_pl_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
742,med-d-XXL_VLDL_TG_agetert1,37127,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_tg_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
743,med-d-XXL_VLDL_TG_agetert2,38784,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_tg_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
744,med-d-XXL_VLDL_TG_agetert3,39167,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_tg_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
745,med-d-XXL_VLDL_TG_pct_agetert1,35865,Males and females,Continuous,agetert1,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_tg_pct_int_agetert1_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
746,med-d-XXL_VLDL_TG_pct_agetert2,37666,Males and females,Continuous,agetert2,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_tg_pct_int_agetert2_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
747,med-d-XXL_VLDL_TG_pct_agetert3,38100,Males and females,Continuous,agetert3,INT,public,HG19/GRCh37,Bell JA,2021,European,Triglycerides to total lipids ratio in chylomicrons and extremely large VLDL,NA,NA,xxl_vldl_tg_pct_int_agetert3_imputed.txt.gz,12321875,tab,TRUE,1,0,1,2,4,5,6,10,11,15
